5 Key Takeaways
-
1
Selective laser trabeculoplasty (SLT) is associated with slower structural glaucoma progression as measured by optical coherence tomography (OCT).
-
2
A retrospective study presented at the 2026 ARVO meeting showed significant slowing of RNFL thinning after SLT treatment.
-
3
The study included 25 eyes with a mean age of 63 years, highlighting the demographic of subjects affected by glaucoma.
-
4
Results indicated that SLT not only reduces intraocular pressure but also slows structural progression of glaucoma.
-
5
These findings support the earlier use of SLT and emphasize its role in preserving optic nerve health in glaucoma patients.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.